Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive
Conditions
Endometrial Cancer - Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cancer - Gastrointestinal Carcinoma - Pancreatic Carcinoma - Lung Cancer - Esophageal Carcinoma
Conditions: official terms
Carcinoma - Esophageal Neoplasms - Pancreatic Neoplasms
Conditions: Keywords
NBI, ENDOMETRIUM, FALLOPIAN TUBE, OVARY, PERITONEUM, Surgery, Lung, Pancreatic, Esophageal, thorascopic, laparoscopic, robotic, 10-180
Study Type
Interventional
Study Phase
N/A
Study Design
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Intervention
Name: Narrow Band Imaging (NBI)
Type: Other
Overall Status
Recruiting
Summary
The purpose of this study is to determine whether narrowband imaging (NBI) makes it easier for a surgeon to see cancer.

NBI is a kind of light. Normally, white light is used during surgery. White light uses many wavelengths of light. NBI only uses two wavelengths which highlight the blood vessels. This makes it easier for the surgeon to see blood vessels. Tumors often have more blood vessels than normal tissue. As a result, NBI may make it easier for the surgeon to see small tumors.

In this study the surgeon will look with both normal white light and NBI. This way a comparison can be made to determine which is superior.

Improved identification of tumors allows doctors and patients to make informed decisions about whether treatment is needed after surgery. It also provides additional information to determine which treatments may be best.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 19 Years
Gender: Both
Criteria: Inclusion Criteria:

- Patients must meet one (or more) of the following criteria:

- Preoperative diagnosis of ovarian, fallopian tube, or primary peritoneal carcinoma (all stage, grade and histology)

- Preoperative diagnosis of grade III endometrial carcinoma (all stage, all histology)

- Preoperative diagnosis of uterine serous carcinoma (all stage, all grade)

- Preoperative diagnosis of clear cell endometrial carcinoma (all stage, all grade)

- Preoperative diagnosis of endometrial carcinosarcoma (all stage, all grade)

- Gastrointestinal carcinoma (all histology, stage and grade)

- Pancreatic carcinoma (all histology, stage and grade)

- Lung cancer (all histology, stage and grade)

- Esophageal carcinoma (all histology, stage and grade)

- Suspected or pathologically confirmed metastatic disease to the lung (all disease primaries)

- Suspected or pathologically confirmed malignant pleural effusion (all disease primaries)

Patients must meet all of the following criteria:

- Planned thorascopic robotic or laparoscopic surgical approach

- >18 years old

- Not pregnant

- Able to give consent Participation in other research protocols does not exclude a patient from participation in this study.

Exclusion Criteria:

- None
Location
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Status: Recruiting
Contact: Nadeem Abu-Rustum, MD - 212-639-7051
Start Date
December 2010
Completion Date
December 2016
Sponsors
Memorial Sloan Kettering Cancer Center
Source
Memorial Sloan Kettering Cancer Center
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page